Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Sanara MedTech
(NASDAQ:SMTI)
Intraday
$31.23
-0.61
[-1.92%]
After-Hours
$31.84
0.6100
[1.95%]
Get Report
Watch
Perks
Buy
Compare Brokers
$31.23
-0.61
[-1.92%]
At close: May 1
$31.84
0.6100
[1.95%]
After Hours: 4:02PM EDT
Get Report
Watch
Q1 2024 Earnings in 12 days from now on Mon May 13th, after the market close
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Sanara MedTech Stock (NASDAQ:SMTI)
Sanara MedTech Stock (NASDAQ: SMTI)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, April 18, 2024
Sanara MedTech Entered Into $55M Non-Dilutive Term Loan Agreement With CRG Servicing To Support Growth Initiatives In 2024 And 2025
Benzinga Newsdesk
-
Apr 18, 2024, 9:16AM
Wednesday, March 27, 2024
Cantor Fitzgerald Maintains Overweight on Sanara MedTech, Lowers Price Target to $44
Benzinga Newsdesk
-
Mar 27, 2024, 9:57AM
Monday, March 25, 2024
Sanara MedTech Q4 EPS $(0.03) Beats $(0.13) Estimate, Sales $17.69M Beat $16.50M Estimate
Happy Mohamed
-
Mar 25, 2024, 4:14PM
Earnings Scheduled For March 25, 2024
Benzinga Insights
-
Mar 25, 2024, 5:33AM
Friday, March 22, 2024
Sanara MedTech's Earnings: A Preview
Benzinga Insights
-
Mar 22, 2024, 10:00AM
Thursday, February 22, 2024
Sanara MedTech Sees Prelim. Q4 2023 Revenue ~$17.7M Vs $16.50M Est.
Benzinga Newsdesk
-
Feb 22, 2024, 9:16AM
Tuesday, February 06, 2024
Cantor Fitzgerald Reiterates Overweight on Sanara MedTech, Maintains $49 Price Target
Benzinga Newsdesk
-
Feb 6, 2024, 9:50AM
Wednesday, January 03, 2024
Sanara Medtech Announced That Is Has Signed An Exclusive License Agreement With Tufts University To Develop And Commercialize Patented Technology Covering 18 Unique Collagen Peptides
Benzinga Newsdesk
-
Jan 3, 2024, 9:18AM
Thursday, November 30, 2023
Sanara MedTech Inc. Announces The Publication of A 5,335 Patient Study Demonstrating A Significant Reduction In Surgical Site Infections When Activated Collagen (CellerateRX Surgical Powder) Was Used To Promote Wound Healing
Benzinga Newsdesk
-
Nov 30, 2023, 9:19AM
Wednesday, November 15, 2023
Cantor Fitzgerald Maintains Overweight on Sanara MedTech, Lowers Price Target to $49
Benzinga Newsdesk
-
Nov 15, 2023, 8:56AM
Tuesday, November 14, 2023
Sanara MedTech shares are trading higher after the company reported a year-over-year increase in Q3 EPS results.
Benzinga Newsdesk
-
Nov 14, 2023, 2:24PM
Monday, November 13, 2023
Sanara MedTech Q3 EPS $(0.13) Up From $(0.18) YoY, Sales $16.02M Miss $18.80M Estimate
Benzinga Newsdesk
-
Nov 13, 2023, 4:15PM
Earnings Scheduled For November 13, 2023
Benzinga Insights
-
Nov 13, 2023, 6:40AM
Friday, November 10, 2023
Earnings Outlook For Sanara MedTech
Benzinga Insights
-
Nov 10, 2023, 10:00AM
Tuesday, October 10, 2023
Sanara MedTech Announces First Sale Of ALLOCYTE Plus Advanced Viable Bone Matrix
Bill Haddad
-
Oct 10, 2023, 9:19AM
Tuesday, September 26, 2023
Cantor Fitzgerald Reiterates Overweight on Sanara MedTech, Maintains $59 Price Target
Benzinga Newsdesk
-
Sep 26, 2023, 12:00PM
Tuesday, August 22, 2023
Cantor Fitzgerald Reiterates Overweight on Sanara MedTech, Maintains $59 Price Target
Benzinga Newsdesk
-
Aug 22, 2023, 11:46AM
Thursday, August 17, 2023
Cantor Fitzgerald Reiterates Overweight on Sanara MedTech, Maintains $59 Price Target
Benzinga Newsdesk
-
Aug 17, 2023, 11:47AM
Monday, August 14, 2023
Sanara MedTech Q2 EPS $(0.22) Misses $(0.13) Estimate, Sales $15.75M Miss $16.90M Estimate
Benzinga Newsdesk
-
Aug 14, 2023, 4:16PM
Earnings Scheduled For August 14, 2023
Benzinga Insights
-
Aug 14, 2023, 6:45AM
Wednesday, August 02, 2023
Sanara MedTech Inc. Announces The Acquisition Of Certain Assets Related To Its Collagen Products Business; The Initial Purchase Price For The Assets That Were Acquired By The Company Is $15.25M
Happy Mohamed
-
Aug 2, 2023, 9:17AM
Monday, May 15, 2023
Sanara MedTech: Q1 Earnings Insights
Benzinga Insights
-
May 15, 2023, 4:30PM
Sanara MedTech Q1 Sales $15.50M Miss $16.20M Estimate
Benzinga Newsdesk
-
May 15, 2023, 4:22PM
Earnings Scheduled For May 15, 2023
Benzinga Insights
-
May 15, 2023, 5:32AM
Monday, March 20, 2023
Sanara MedTech FY22 Revenue $45.8M, Up 90% YoY
Bill Haddad
-
Mar 20, 2023, 4:06PM
Earnings Scheduled For March 20, 2023
Benzinga Insights
-
Mar 20, 2023, 5:27AM
Friday, March 17, 2023
Earnings Outlook For Sanara MedTech
Benzinga Insights
-
Mar 17, 2023, 10:00AM
Friday, February 24, 2023
Sanara MedTech Says Co. Entered Into Sales Agreement With Cantor Fitzgerald Relating To $75M Of Common Stock Shares Offered By Prospectus
Michael Horton
-
Feb 24, 2023, 4:32PM
Wednesday, February 22, 2023
Sanara MedTech Inc. Announces Unaudited Preliminary Results For Q4 And FY22; Q4 Net Revenue Of $15.3M; FY22 Net Revenue Of $45.8M
Happy Mohamed
-
Feb 22, 2023, 9:19AM
Monday, November 14, 2022
Sanara MedTech Q3 Sales $13.00M Miss $14.70M Estimate
Michael Horton
-
Nov 14, 2022, 4:24PM
Earnings Scheduled For November 14, 2022
Benzinga Insights
-
Nov 14, 2022, 5:06AM
Thursday, November 03, 2022
InfuSystem and Sanara MedTech Announced Wound Therapy Partnership
Charles Gross
-
Nov 3, 2022, 6:34AM
Monday, August 15, 2022
Sanara MedTech Q2 Sales $9.70M Beat $7.81M Estimate
Michael Horton
-
Aug 15, 2022, 4:30PM
Earnings Scheduled For August 15, 2022
Benzinga Insights
-
Aug 15, 2022, 4:30AM
Monday, May 16, 2022
Sanara MedTech Q1 Sales $7.80M Up From $5.01M YoY
Benzinga Newsdesk
-
May 16, 2022, 4:59PM
Earnings Scheduled For May 16, 2022
Benzinga Insights
-
May 16, 2022, 5:18AM
Monday, April 04, 2022
Sanara MedTech Inc. Announces Entry Into Merger Agreement To Acquire Precision Healing Inc For $5.1M In Cash And Stock
Benzinga Newsdesk
-
Apr 4, 2022, 6:33AM
Wednesday, March 30, 2022
Sanara MedTech FY21 Net Loss $8M vs Loss $4.4M In FY20
Benzinga Newsdesk
-
Mar 30, 2022, 4:20PM
Earnings Scheduled For March 30, 2022
Benzinga Insights
-
Mar 30, 2022, 4:52AM
Tuesday, March 29, 2022
Sanara MedTech's Earnings Outlook
Benzinga Insights
-
Mar 29, 2022, 10:05AM
Tuesday, February 22, 2022
Sanara MedTech Sees Prelim. Q4 Sales $7M vs $6.1M Est., Sees Prelim. FY21 Sales $24.1M v $23.3M Est.
Bill Haddad
-
Feb 22, 2022, 9:16AM
Wednesday, December 29, 2021
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
Dec 29, 2021, 1:15PM
Tuesday, December 28, 2021
Sanara MedTech Names Zachary Fleming As CEO
Benzinga Newsdesk
-
Dec 28, 2021, 9:20AM
Friday, November 12, 2021
Sanara MedTech Q3 EPS $(0.27) Misses $(0.18) Estimate, Sales $5.82M Miss $6.30M Estimate
Benzinga Newsdesk
-
Nov 12, 2021, 4:24PM
Earnings Scheduled For November 12, 2021
Benzinga Insights
-
Nov 12, 2021, 4:26AM
Monday, August 16, 2021
Earnings Scheduled For August 16, 2021
Benzinga Insights
-
Aug 16, 2021, 4:04AM
Wednesday, June 30, 2021
Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2021
Benzinga Insights
-
Jun 30, 2021, 10:16AM
Cantor Fitzgerald Initiates Coverage On Sanara MedTech with Overweight Rating, Announces Price Target of $45
Benzinga Newsdesk
-
Jun 30, 2021, 7:30AM
Friday, June 04, 2021
Sanara MedTech Announces Exclusive Partnership With Pixalere Healthcare To Advance Comprehensive Wound And Skin Care Strategy
Benzinga Newsdesk
-
Jun 4, 2021, 9:18AM
Monday, March 15, 2021
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Mar 15, 2021, 2:08PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
